Keap1-Nrf2-IN-23 (compound 56) is an inhibitor of the Keap1–Nrf2 PPI ( IC 50 =16.0 nM). Keap1-Nrf2-IN-23 binds to Keap1 with a K d value of 3.07 nM. Keap1-Nrf2-IN-23 has oral activity.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > NF-κB | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Keap1-Nrf2
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.